Professor is surgery
Plastic Surgery
Dr. Stephan Ariyan, MD
|
|
Give Review
Stephan Ariyan works in the field of Plastic Surgery. He researched medicine at Yale University School of Medicine. Yale University School of Medicine is a top medical university. Yale University School of Medicine is ranked 7/57 in Research/PrimaryCare. He has 32 awards "Robert Goldwyn Lifetime Achievement Award", "Distinguished Fellow", "Presidential Citation", "Presidential Award", "Distinguished Service Award", "CMS Meaningful Use Stage 1 Certification", "Clinical Excellence Award", "Top Doctors", "Top Doctors of New York Metro Area", "Best Doctors of New York", "How To Find the Best Doctors", "First Prize, Essay", "National Visiting Professor", "Best Doctors in America", "Kabakjian Award, Outstanding Contribution in a Field of Science", "Best Breast Cancer Doctors", "Outstanding Medical Specialists in the US", "Distinguished Teacher Award", "First Prize, Basic Science Research", "Third Prize, Clinical Research", "Honorable Mention, Resident Papers", "First Prize in Head and Neck Surgery, Plastic Surgery Chief Resident's Conference", "First Prize, Resident Papers", "Honorable Mention, Resident Papers, Connecticut Chapter", "First Prize in Basic Research, Plastic Surgery Chief Resident's Conference", "Sigma Xi", "Scholar", "NY State Partial Scholarship", "Alpha Epsilon Delta", "Phi Sigma", "Trustees' Full Scholarship" and "Fellow (FACS)". Stephan Ariyan is also published. He has 51 publications published. The lastest publication: "Rim mandibulectomy for cancer of the oral cavity.' Doctor Stephan Ariyan, MD accepts Medicare payments and is registered with Medicare.gov.
Publications
- Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b ...
- Antibiotic Prophylaxis for Preventing Surgical Site Infection in Plastic Surgery: An Evidence Based Consensus Conference Statement from the American Association of Pla...
- Using topical imiquimod for the management of positive in situ margins after melanoma resection.
- Scalp Melanoma and In-transit Metastases: A Retrospective Case-controlled Study.
- Clinical characteristics associated with Spitz nevi and Spitzoid malignant melanomas: The Yale University Spitzoid Neoplasm Repository experience, 1991 to 2008.
- Abstract 37: the value of performing frozen section on sentinel lymph node biopsy in patients with melanoma.
- A targeted approach to sentinel lymph node biopsies in the parotid region for head and neck melanomas.
- Level I sparing radical neck dissections for cutaneous melanoma in the lymphoscintigram era.
- Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.
- A proposal for the timing of management of patients with melanoma presenting during pregnancy.
- Preservation of muscle fascia to decrease lymphedema after complete axillary and ilioinguinofemoral lymphadenectomy for melanoma.
- Merkel cell carcinoma: five case reports using sentinel lymph node biopsy and a review of 110 new cases.
- The transverse platysma myocutaneous flap for head and neck reconstruction: an update.
- Further experience with the sternocleidomastoid myocutaneous flap.
- Use of the operating microscope and loupes for head and neck free microvascular tissue transfer: a retrospective comparison.
- Regional isolated perfusion of extremities for melanoma: now a 26-year experience with drugs other than L-phenylalanine mustard.
- Pulse oximetry declines due to intradermal isosulfan blue dye: a controlled prospective study.
- Her2/neu is not a commonly expressed therapeutic target in melanoma -- a large cohort tissue microarray study.
- Reliability of identification of 655 sentinel lymph nodes in 263 consecutive patients with malignant melanoma.
- Microsurgical free flap reconstruction outcomes in head and neck Cancer patients after surgical extirpation and intraoperative brachytherapy.
- Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas.
- Gender-related differences in outcome for melanoma patients.
- Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.
- Rab33A: characterization, expression, and suppression by epigenetic modification.
- The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization.
- Diagnosis and treatment of interval sentinel lymph nodes in patients with cutaneous melanoma.
- Reliability of lymphatic mapping after wide local excision of cutaneous melanoma.
- Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis.
- Sentinel lymph node biopsies in melanoma: how many nodes do we really need?
- Toxicity and activity of a twice daily high-dose bolus interleukin 2 regimen in patients with metastatic melanoma and metastatic renal cell Cancer.
- A randomized study comparing the effectiveness of methylene blue dye with lymphazurin blue dye in sentinel lymph node biopsy for the treatment of cutaneous melanoma.
- Effect of multiple-nodal basin drainage on cutaneous melanoma.
- Integrative analysis of epigenetic modulation in melanoma cell response to decitabine: clinical implications.
- Management of the difficult sentinel lymph node in patients with primary cutaneous melanoma.
- Genome-wide screen of promoter methylation identifies novel markers in melanoma.
- Cadaveric allograft for wound closure after resection of squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: a report of 32 resections...
- Melanoma prognostic model using tissue microarrays and genetic algorithms.
- Factors associated with false-negative sentinel lymph node biopsy in melanoma patients.
- Metachronous primary melanoma and lymphoma.
- PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells.
- Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032.
- Melanoma of the head and neck.
- Plasma markers for identifying patients with metastatic melanoma.
- Excising value at a marginal cost: rethinking the management of Basal cell carcinoma.
- MicroRNA signatures differentiate melanoma subtypes.
- Detecting copy number status and uncovering subclonal markers in heterogeneous tumor biopsies.
- A prospective trial on the use of antibiotics in hand surgery.
- Current surgical treatment in melanoma.
- Melanoma brain metastases: is it time to reassess the bias?
- Rim mandibulectomy for Cancer of the oral cavity.
Schools
New York Medical College
Procedures Preformed
- Adjacent Tissue Transfer
- Breast Reconstruction
- Excision of Benign Skin Lesion
- Excision of Malignant Skin Lesion
- View All
Conditions Treated
- Benign Skin Lesion
- Skin Cancer
Doctors Specialties
- General Surgery
- Plastic Surgery
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Pathway X Ind PPO Direct Access CT
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Connecticare HMO
- Connecticare POS
- GEHA
- Medicare MCR
- Meritain Health
- MultiPlan PPO
- PHCS Network PPO
- MVP Health Care
- Freedom Plan
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- Oxford Liberty
- United Healthcare
Awards
- Robert Goldwyn Lifetime Achievement Award
- Distinguished Fellow
- Presidential Citation
- Presidential Award
- Distinguished Service Award
- CMS Meaningful Use Stage 1 Certification
- Clinical Excellence Award
- Top Doctors
- Top Doctors of New York Metro Area
- Best Doctors of New York
- How To Find the Best Doctors
- First Prize, Essay
- National Visiting Professor
- Best Doctors in America
- Kabakjian Award, Outstanding Contribution in a Field of Science
- Best Breast Cancer Doctors
- Outstanding Medical Specialists in the US
- Distinguished Teacher Award
- First Prize, Basic Science Research
- Third Prize, Clinical Research
- Honorable Mention, Resident Papers
- First Prize in Head and Neck Surgery, Plastic Surgery Chief Resident's Conference
- First Prize, Resident Papers
- Honorable Mention, Resident Papers, Connecticut Chapter
- First Prize in Basic Research, Plastic Surgery Chief Resident's Conference
- Sigma Xi
- Scholar
- NY State Partial Scholarship
- Alpha Epsilon Delta
- Phi Sigma
- Trustees' Full Scholarship
- Fellow (FACS)
Education
-
Yale University School of Medicine -
Yale-New Haven Hospital -
University of California San Diego -
Harbor - UCLA Medical Center -
New York Medical College
Hospital
-
Yale-New Haven Hospital
Drug Facts
| NPI NUMBER | 1578583282 | |
| NPPES Provider LastName | ARIYAN | |
| NPPES Provider FirstName | STEPHAN | |
| NPPES Provider ZIPCode | 065102716 | |
| NPPES Provider State | CT | |
| Specialty Description | Surgical Oncology | |
| Total Claim Count | 31.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1578583282 |
| Last Name Of The Provider | ARIYAN |
| First Name Of The Provider | STEPHAN |
| View All |
Similar Doctors
|
|
Dr. Zeno N. Chicarilli, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deepak Narayan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Javier J. Davila, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark H. Weinstein, MD |
|
|
Dr. Stephen V. Flagg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie A. Sosa, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Christopher McLaughlin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher C. Chang, MD |
|
|
Dr. Irvin M. Modlin, MD |
|
|
Dr. Vladimir Shumaster, MD |
|
|
Dr. John P. Kelly, MD |
|
|
Dr. Ajul Shah, MD |
|
|
Dr. Willis T. Williams, MD |
|
|
Dr. Ahmad N. Saad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter S. Yoo, MD
This Doctor is OpenDoctor Recommended.
|